Stock listing

Inflarx N.v.

Selected listing: A2H7A5 · LS · EUR · DE

Inflarx N.v. (Lang & Schwarz: A2H7A5), Health Technology. Latest release Oct 2, 2026: InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney…

A2H7A5:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A2H7A5
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Inflarx N.v.

InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026

October 1, 2026

InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026

October 2, 2026

InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President and Global Head of Clinical Development

October 2, 2026

InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development

September 30, 2026

InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development

October 1, 2026

All Inflarx N.v. news →

Research Inflarx N.v.

Inflarx N.v. company profile

View the public company page for Inflarx N.v. on 6ix.

Inflarx N.v. news

Read company news and market updates connected to Inflarx N.v..

Inflarx N.v. investor events

Find investor webinars, events, and replay context for Inflarx N.v..